Live from TTLC25: Targeted Therapy in Early-Stage NSCLC Podcast

Podcast | English | 2025 | 25 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

Join us in a live discussion with Drs. Narjust Florez, Jessica Lin, and Jared Weiss talk about the pros and cons of targeted therapy in early-stage NSCLC, from their anecdotes about the debate to future studies in this setting.

Podcast Hosts:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Jessica J. Lin, MD, Associate Professor of Medicine, Harvard Medical School, Attending Physician, Massachusetts General Hospital, Boston, MA, USA
Jared Weiss, MD, Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology, University of North Carolina, Chapel Hill, NC, USA